170 related articles for article (PubMed ID: 22178447)
1. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer.
Greenwood C; Metodieva G; Al-Janabi K; Lausen B; Alldridge L; Leng L; Bucala R; Fernandez N; Metodiev MV
J Proteomics; 2012 Jun; 75(10):3031-40. PubMed ID: 22178447
[TBL] [Abstract][Full Text] [Related]
2. CD74: a potential novel target for triple-negative breast cancer.
Tian B; Zhang Y; Li N; Liu X; Dong J
Tumour Biol; 2012 Dec; 33(6):2273-7. PubMed ID: 22935920
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD74 in invasive breast carcinoma: its relation to Nottingham Prognostic Index, hormone receptors, and HER2 immunoprofile.
Hasby EA; Khalifa RA
Tumori; 2017 Mar; 103(2):193-203. PubMed ID: 27834468
[TBL] [Abstract][Full Text] [Related]
4. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells.
Liu Z; Chu S; Yao S; Li Y; Fan S; Sun X; Su L; Liu X
Oncotarget; 2016 Oct; 7(42):68303-68313. PubMed ID: 27626171
[TBL] [Abstract][Full Text] [Related]
5. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
6. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Verjans E; Noetzel E; Bektas N; Schütz AK; Lue H; Lennartz B; Hartmann A; Dahl E; Bernhagen J
BMC Cancer; 2009 Jul; 9():230. PubMed ID: 19602265
[TBL] [Abstract][Full Text] [Related]
7. CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells.
Metodieva G; Nogueira-de-Souza NC; Greenwood C; Al-Janabi K; Leng L; Bucala R; Metodiev MV
Neoplasia; 2013 Jun; 15(6):660-8. PubMed ID: 23730214
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
9. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis.
Roos A; Preusse C; Hathazi D; Goebel HH; Stenzel W
Front Immunol; 2019; 10():1040. PubMed ID: 31143183
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.
Hassan HN; Al-Hussein RKA; Al-Naqeeb AA
Pol Merkur Lekarski; 2024; 52(2):233-239. PubMed ID: 38642360
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor-associated macrophages in breast carcinoma invasion and metastasis.
Yang J; Li X; Liu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(6):6656-64. PubMed ID: 26261547
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis.
Croner RS; Stürzl M; Rau TT; Metodieva G; Geppert CI; Naschberger E; Lausen B; Metodiev MV
Int J Cancer; 2014 Dec; 135(12):2878-86. PubMed ID: 24771638
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
[TBL] [Abstract][Full Text] [Related]
15. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
[TBL] [Abstract][Full Text] [Related]
16. Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis.
Faktor J; Knopfova L; Lapcik P; Janacova L; Paralova V; Bouchalova P; Muller P; Benes P; Bouchal P
Proteomics; 2019 Nov; 19(21-22):e1900073. PubMed ID: 31617665
[TBL] [Abstract][Full Text] [Related]
17. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis.
Loreth D; Schuette M; Zinke J; Mohme M; Piffko A; Schneegans S; Stadler J; Janning M; Loges S; Joosse SA; Lamszus K; Westphal M; Müller V; Glatzel M; Matschke J; Gebhardt C; Schneider SW; Belczacka I; Volkmer B; Greinert R; Yaspo ML; Harter PN; Pantel K; Wikman H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209696
[TBL] [Abstract][Full Text] [Related]
18. Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives.
To B; Isaac D; Andrechek ER
J Mammary Gland Biol Neoplasia; 2020 Sep; 25(3):191-203. PubMed ID: 33034778
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
Li M; Li A; Zhou S; Xu Y; Xiao Y; Bi R; Yang W
BMC Cancer; 2018 Jan; 18(1):4. PubMed ID: 29291717
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin B: a potential prognostic marker for inflammatory breast cancer.
Nouh MA; Mohamed MM; El-Shinawi M; Shaalan MA; Cavallo-Medved D; Khaled HM; Sloane BF
J Transl Med; 2011 Jan; 9():1. PubMed ID: 21199580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
